Literature DB >> 15220214

Remapping the insulin gene/IDDM2 locus in type 1 diabetes.

Bryan J Barratt1, Felicity Payne, Chris E Lowe, Robert Hermann, Barry C Healy, Denise Harold, Patrick Concannon, Neda Gharani, Mark I McCarthy, Mark G Olavesen, Rose McCormack, Cristian Guja, Constantin Ionescu-Tîrgovişte, Dag E Undlien, Kjersti S Rønningen, Kathleen M Gillespie, Eva Tuomilehto-Wolf, Jaakko Tuomilehto, Simon T Bennett, David G Clayton, Heather J Cordell, John A Todd.   

Abstract

Type 1 diabetes susceptibility at the IDDM2 locus was previously mapped to a variable number tandem repeat (VNTR) 5' of the insulin gene (INS). However, the observation of associated markers outside a 4.1-kb interval, previously considered to define the limits of IDDM2 association, raised the possibility that the VNTR association might result from linkage disequilibrium (LD) with an unknown polymorphism. We therefore identified a total of 177 polymorphisms and obtained genotypes for 75 of these in up to 434 pedigrees. We found that, whereas disease susceptibility did map to within the 4.1-kb region, there were two equally likely candidates for the causal variant, -23HphI and +1140A/C, in addition to the VNTR. Further analyses in 2,960 pedigrees did not support the difference in association between VNTR lineages that had previously enabled the exclusion of these two polymorphisms. Therefore, we were unable to rule out -23HphI and +1140A/C having an etiological effect. Our mapping results using robust regression methods show how precisely a variant for a common disease can be mapped, even within a region of strong LD, and specifically that IDDM2 maps to one or more of three common variants in a approximately 2-kb region of chromosome 11p15.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220214     DOI: 10.2337/diabetes.53.7.1884

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  89 in total

Review 1.  Understanding type 1 diabetes through genetics: advances and prospects.

Authors:  Constantin Polychronakos; Quan Li
Journal:  Nat Rev Genet       Date:  2011-10-18       Impact factor: 53.242

2.  Novel gene associations in type 1 diabetes.

Authors:  Jorma Ilonen; Robert Hermann
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

3.  Making the right associations.

Authors:  M I McCarthy; P-H Groop; T Hansen
Journal:  Diabetologia       Date:  2005-07       Impact factor: 10.122

Review 4.  Genetic epidemiology of diabetes.

Authors:  M Alan Permutt; Jonathon Wasson; Nancy Cox
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

Review 5.  Reliability of statistical associations between genes and disease.

Authors:  Kenneth F Manly
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

6.  The relation between size at birth and risk of type 1 diabetes is not influenced by adjustment for the insulin gene (-23HphI) polymorphism or HLA-DQ genotype.

Authors:  L C Stene; P M Thorsby; J P Berg; K S Rønningen; D E Undlien; G Joner
Journal:  Diabetologia       Date:  2006-05-12       Impact factor: 10.122

Review 7.  Systems biology and heart failure: concepts, methods, and potential research applications.

Authors:  Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

Review 8.  Genome-wide association studies in type 1 diabetes.

Authors:  Struan F A Grant; Hakon Hakonarson
Journal:  Curr Diab Rep       Date:  2009-04       Impact factor: 4.810

9.  DNA methylation near the INS gene is associated with INS genetic variation (rs689) and type 1 diabetes in the Diabetes Autoimmunity Study in the Young.

Authors:  Patrick M Carry; Lauren A Vanderlinden; Randi K Johnson; Fran Dong; Andrea K Steck; Brigitte I Frohnert; Marian Rewers; Ivana V Yang; Katerina Kechris; Jill M Norris
Journal:  Pediatr Diabetes       Date:  2020-02-28       Impact factor: 4.866

10.  The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.

Authors:  C Julier; B Akolkar; P Concannon; G Morahan; C Nierras; A Pugliese
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.